References
- Abram, K., Silm, H., Maaroos, H.I., & Oona, M. (2009). Subjective disease perception and symptoms of depression in relation to healthcare-seeking behaviour in patients with rosacea. Acta Dermato Venereologica, 89, 488–491.
- Aksoy, B., Altaykan-Hapa, A., Egemen, D., Karagoz, F., & Atakan, N. (2010). The impact of rosacea on quality of life: Effects of demographic and clinical characteristics and various treatment modalities. British Journal of Dermatology, 163, 719–725.
- Böhm, D., Stock Gissendanner, S., Snitjer, K., Snitjer, I., Werfel, T., Weyergraf, W., …Schmid-Ott, G. (2013). Perceived relationships between severity of psoriasis symptoms, gender, stigmatization and quality of life. Journal of the European Academy of Dermatology and Venereology, 27, 220–226.
- Finlay, A.Y., & Khan, G.K. (1994). Dermatology life quality index (DLQI) – A simple practical measure for routine clinical use. Clinical and Experimental Dermatology, 19, 210–216.
- Fortune, D.G., Richards, H.L., Kirby, B., Bowcock, S., Main, C.J., & Griffiths, C.E.M. (2002). A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. British Journal of Dermatololgy, 146, 458–465.
- Gupta, M.A., Gupta, A.K., Chen, S.J., & Johnson, A.M. (2005). Comorbidity of rosacea and depression: An analysis of the National Ambulatory Medical Care Survey and National Hospital Ambulatory Care Survey – Outpatient department data collected by the US National Center for Health Statistics from 1995 to 2002. British Journal of Dermatology, 153, 1176–1181.
- Herrmann, C., Buss, U., & Snaith, R.P. (1995). Hospital anxiety and depression scale-deutsche version (HADS-D) manual (1st ed.). Bern: Hans Huber.
- Hiltscher, D. (2001). Clinical practice, therapy, risk factors, and life quality among patients with rosacea and rhinophyma (Unpublished doctoral dissertation). Ruprecht Karls University, Heidelberg.
- Schmid-Ott, G., Burchard, R., Niederauer, H.H., Lamprecht, F., & Kunsebeck, H.W. (2003). Stigmatisierungsgefühl und Lebensqualität bei Patienten mit Psoriasis und Neurodermitis [Feeling of stigmatization and quality of life of patients with psoriasis and atopic dermatitis]. Hautarzt, 54, 852–857.
- Schmid-Ott, G., Kunsebeck, H.W., Jecht, E., Shimshoni, R., Lazaroff, I., Schallmayer, S., ... Götz, A. (2007). Stigmatization experience, coping and sense of coherence in vitiligo patients. Journal of the European Academy of Dermatology and Venereology, 21, 456–461.
- Spoendlin, J., Voegel, J.J., Jick, S.S., & Meier, C.R. (2012). A study on the epidemiology of rosacea in the UK. British Journal of Dermatology, 167, 598–605.
- Su, D., & Drummond, P.D. (2012). Blushing propensity and psychological distress in people with rosacea. Clinical Psychology and Psychotherapy, 19, 488–495.
- Tan, J., Blume-Peytavi, U., Ortonne, J.P., Wilhelm, K., Marticou, L., Baltas, E., Rivier, M., Petit, L., & Martel, P. (2013). An observational cross-sectional survey of rosacea: Clinical associations and progression between subtypes. British Journal of Dermatology. doi:10.1111/bjd.12385
- Wittkowski, A., Richards, H.L., Griffiths, C.E., & Main, C.J. (2004). The impact of psychological and clinical factors on quality of life in individuals with atopic dermatitis. Journal of Psychosomatic Research, 57, 195–200.